Prospective population-level validation of the Abbott ID NOW severe acute respiratory syndrome coronavirus 2 device implemented in multiple settings for testing asymptomatic and symptomatic individuals

OBJECTIVE: Diagnostic evaluation of the ID NOW coronavirus disease 2019 (COVID-19) assay in various real-world settings among symptomatic and asymptomatic individuals. METHODS: Depending on the setting, the ID NOW testing was performed using oropharyngeal swabs (OPSs) taken from patients with sympto...

Descripción completa

Detalles Bibliográficos
Autores principales: Stokes, William, Venner, Allison A., Buss, Emily, Tipples, Graham, Berenger, Byron M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463071/
https://www.ncbi.nlm.nih.gov/pubmed/36096431
http://dx.doi.org/10.1016/j.cmi.2022.08.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463071/
https://www.ncbi.nlm.nih.gov/pubmed/36096431
http://dx.doi.org/10.1016/j.cmi.2022.08.025

Ejemplares similares